Predictors of Delayed Therapy after Expectant Management for Localized Prostate Cancer in the Era of Prostate-Specific Antigen

Publisher： Karger

E-ISSN： 1423-0232|67|3-4|194-202

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.3-4, 2004-11, pp. : 194-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Managing localized prostate cancer in the era of prostate‐specific antigen screening

By  

CANCER, Vol. 119, Iss. 22, 2013-11 ,pp. : 3906-3909

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 217-221

Karger

Access to resources Recommend Favorite

Usefulness of the Nadir Value of Serum Prostate-Specific Antigen Measured by an Ultrasensitive Assay as a Predictor of Biochemical Recurrence after Radical Prostatectomy for Clinically Localized Prostate Cancer

By  

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 227-231

Karger

Access to resources Recommend Favorite

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2795-2802

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comprehensive assessment for novel prostate cancer markers in the prostate‐specific antigen era: Focusing on Asians and Asian countries

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 4, 2015-04 ,pp. : 334-341

John Wiley & Sons Inc

Access to resources Recommend Favorite